¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Veni-Prep III/Site Care Misc"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ambulatory care
    ¿Ü·¡Áø·á, Åë¿øÁø·á
  • baby care
    À¯¾Æ°£È£
  • bowel care
    ¹èº¯°ü¸®
  • community care
    Áö¿ª»çȸ°¡·á
  • community medical care
    Áö¿ª»çȸÀÇ·á
  • comprehensive health care
    Æ÷°ýº¸°ÇÀÇ·á
  • coronary care unit
    °ü»óµ¿¸ÆÁýÁßÄ¡·á½Ç, ½ÉÀ嵿¸ÆÁýÁßÄ¡·á½Ç
  • critical care medicine
    ÁßȯÀÚÄ¡·áÀÇÇÐ
  • care
    1. ÀÇ·á, Áø·á 2. °£È£, µ¹º½
  • day care
    ÁÖ°£µ¹º½, ÁÖ°£°£È£
  • domiciliary care
    ¿ä¾çÄ¡·á
  • emergency care
    ÀÀ±ÞÀÇ·á, ÀÀ±Þóġ
  • health care
    º¸°Ç°ü¸®, °Ç°­°ü¸®
  • health care agent
    1. °Ç°­°ü¸®¿ä¿ø 2. °Ç°­°ü¸®±â±¸
  • health care delivery system
    ÀÇ·áÀü´Þü°è
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • health care worker
    °Ç°­°ü¸®¿ä¿ø, ÀÇ·á±â°üÁ¾»çÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • site
    ºÎÀ§
  • telomeric site
    ¸»´ÜºÎÀ§
  • web site
    À¥½ÎÀÌÆ®
  • ambulatory care
    ¿Ü·¡Áø·á
  • antepartum care
    ºÐ¸¸Àü°£È£
  • health care agent
    °Ç°­°ü¸®¿ä¿ø, °Ç°­°ü¸®±â±¸
  • baby care
    À¯¾Æ°£È£
  • bowel care
    ¹èº¯°ü¸®, âÀÚóġ
  • care
    °¡·á, °£È£
  • community care
    Áö¿ª»çȸ°¡·á
  • community medical care
    Áö¿ª»çȸÀÇ·á
  • coronary care unit
    ½ÉÀ嵿¸ÆÁúȯÁýÁßÄ¡·á½Ç
  • critical care medicine
    ÁßȯÀÚÀÇÇÐ
  • day care
    ÁÖ°£µ¹º½
  • domiciliary care
    ÀÚ°¡Ä¡·á
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • antithrombin III
    Çׯ®·Òºó III
  • apolipoprotein C-III
    ¾ÆÆ÷Áö´Ü¹é C-III
  • arsenazo III dye
    ¾Æ¸£¼¼³ªÁ¶<ºñ¼Ò¾ÆÁ¶> III ¿°·á
  • group III fiber
    Á¦¥²¤Çí·A.
  • group III fiber
    Á¦¥²±º¼¶À¯(ÏØàéë«).
  • hyperlipoproteinemia type III
    °íÁö´Ü¹éÇ÷Áõ III
  • hyperproteinemia type III
    ´Ü¹é°úÀ×Ç÷(Áõ) III Çü
  • hypersensitivity reactions,type iii(imune complex-mediated)
    IIIÇü
  • platelet factor III
    Ç÷¼ÒÆÇÁ¦»ïÀÎÀÚ.
  • procollagen III peptide
    ÇÁ·ÎÄݶó°Õ III ÆéƼµå
  • pseudounipolar(bipolar III) disorder
    °¡¼º ´Ü±Ø¼º(¾ç±Ø¼º III)Àå¾Ö(º´).
  • JCAHO(The Joint Commision of Accreditation of Health Care Organization)
    ¹Ì±¹ º´¿ø½ÅÀÓÀ§¿øÈ¸.
  • after care
    ÈÄÄ¡·á(ý­ö½èþ), Èĺ¸È£(ý­ÜÁûÞ), ȸº¹±âÄ¡·á, ȸº¹±âº¸È£.
  • ambulatory care
    ¿Ü·¡Áø·á
  • antepartum care
    ºÐ¸¸Àü °£È£(ÝÂØ´îñÊ×ûÞ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • absorption site
    Èí¼öÁ¡
  • acceptor site
    ¼ö¿ëºÎÀ§
  • active site
    Ȱ¼ºÀÚ¸®.
  • antibody binding site
    Ç×ü°áÇÕºÎÀ§
  • antibody combining site
    Ç×ü°áÇÕºÎ(ù÷ô÷Ì¿ùêÝ»).
  • antigen binding site
    Ç׿ø°áÇÕºÎÀ§
  • antigen combining site
    Ç׿ø°áÇպΠ(¡­Ì¿ùêÝ»).
  • antigen recognition site
    Ç׿ø½Äº°ºÎ.
  • binding site
    °áÇÕºÎÀ§.
  • binding site
    °á ÇÕºÎÀ§.
  • combining site
    °áÇÕºÎ(Ì¿ùêÝ»).
  • combining site
    °áÇÕºÎÀ§
  • combining site of antibody
    Ç×üÀÇ °áÇÕºÎ.
  • corporal site
    ÀڱøöÅëÀÓ½Å
  • definitive site
    Âø»óÀÚ¸®
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • AP site
    AP ÀÚ¸®
  • A-site
    AÀÚ¸®
  • attachment site
    ºÎÂø(ݾó·)ÀÚ¸®
  • binding site
    °áÇÕ(Ì¿ùê)ÀÚ¸®
  • catalytic site
    Ã˸Å(õºØÚ)ÀÚ¸®
  • codon recognizing site
    ÄÚµ· ÀνÄ(ìããÛ) ÀÚ¸®
  • combining site
    °áÂø(Ì¿ó·)ÀÚ¸®
  • condensing site
    ÃàÇÕ(õêùê)ÀÚ¸®
  • cos site
    cos ÀÚ¸®
  • donor site
    °ø¿©ÀÚ(Íêæ¨í­) ÀÚ¸® = peptidyl site
  • donor splicing site
    "°ø¿©ÀÚ ½ºÇöóÀÌ½Ì ÀÚ¸®, °ø¿©ÀÚ Àß¶óÀÕ±â ÀÚ¸®, (ÔÒ) splicing junctions"
  • D-site
    D-ÀÚ¸® (ÔÒ) donor site
  • entry site
    ÁøÀÔ(òäìý) ÀÚ¸®
  • E site
    E ÀÚ¸®
  • excluded site binding
    ¹èÁ¦(ÛÉð¶)ÀÚ¸® °áÇÕ(Ì¿ùê)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
misc miscarriage; miscellaneous
FS factor of safety; Fanconi syndrome; Felty syndrome; fibromyalgia syndrome; field stimulation; Fisher...
CCC care-cure coordination; cathodal closure contraction; chronic calculous cholecystitis; chronic catar...
PCA para-chloramphetamine; parietal cell antibody; passive cutaneous anaphylaxis; patient care assistant...
PCC Pasteur Culture Collection; percutaneous cecostomy; pheochromocytoma; phosphate carrier compound; pl...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
apoLp-III Apolipophorin III
APO C-III Apolipoprotein C-III
AP III Atriopeptin III
CA III Carbonic anhydrase III
CIN III Cervical intraepithelial neoplasia grade III
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • electrophilic site
    Ä£ÀüÀÚ ¹ÝÀÀ¹°
  • molecular site
    ºÐÀÚ À§
  • receptor site
    ¼ö¿ëü ºÎÀ§, ¼ö¿ëºÎ
    ƯÁ¤ÇÑ »ý¹°ÇÐÀû ¹ÝÀÀÀ» ÃÊ·¡ÇÏ´Â ºÐÀÚ °áÇÕÀÌ ÀϾ´Â ƯÁ¤ ºÎÀ§.
  • recognition site
    ÀÎ½Ä ºÎÀ§
  • site
    À§Ä¡, »çÀÌÆ®
  • site of pain modulation
    µ¿Åë Á¶Àý ºÎÀ§
  • specific opiate receptor site
    Ưº°ÇÑ ¾ÆÆí ¼ö¿ëºÎ
  • specific tender point site
    ƯÁ¤ ¾ÐÅëÁ¡
  • surgical site
    ¼ö¼ú ºÎÀ§
  • web site
    À¥½ÎÀÌÆ®
    ÀÎÅͳݿ¡¼­ ¾î¶² Á¤º¸¸¦ Á¦°øÇϰí ÀÖ´Â ÇϳªÀÇ »çÀ̹ö °ø°£. ÀÎÅÍ³Ý ÁÖ¼Ò°¡ °¡¸®Å°´Â °÷.
  • acute care bed
    ÀÀ±Þ Ä¡·á º´»ó
  • after care
    ÈÄÄ¡·á, Èĺ¸È£, ȸº¹±â Ä¡·á, ȸº¹±â º¸È£, º´ÈÄ Ä¡·á, ÈÄ ¿ä¹ý
    1. º´ ¶Ç´Â ¼ö¼ú ÈÄÀÇ µÞ Á¶¸®. 2. ȸº¹±âÀÇ È¯ÀÚ Æ¯È÷ ¼ö¼úÀ» ¹ÞÀº ȯÀÚÀÇ °£È£¿Í Ä¡·á. 3. Á¦ 2Â÷ ¼¼°è´ëÀü ÀÌÀü¿¡´Â °áÇ٠ȯÀÚ°¡ ¸¹¾Æ ȸº¹±â ȯÀÚ¸¦ ´ë»óÀ¸·Î »çȸÀû ½ÃÃ¥À¸·Î¼­ ½ÃÀÛµÈ °ÍÀ̸ç, °Ç°­ °ü¸®¸¦ Çϸ鼭 ÀÛ¾÷ Áöµµ¸¦ Çϰųª ȯÀÚ°¡ ÀÏÇÒ ¼ö ÀÖ´Â Á÷Àåȯ°æÀ» Á¶¼ºÇϰųª Çß´Ù. ¿À´Ã³¯¿¡´Â ÀçȰ ÀÇÇп¡ À־ ³úÁ¹Áß µî¿¡ ´ëÇØ ¾ÖÇÁÅÍ ÄɾîÀÇ ´Ü¾î°¡ »ç¿ëµÇ´Â ¼ö°¡ ÀÖ´Ù.
  • after-care
    ÈÄ Ä¡·á, ÈÄ º¸È£, ȸº¹±â Ä¡·á, ȸº¹±â º¸È£
    º´À̳ª ¼ö¼ú ÈÄÀÇ µÞÁ¶¸®. ȸº¹±âÀÇ È¯ÀÚ, ƯÈ÷ ¼ö¼úÀ» ¹ÞÀº ȯÀÚÀÇ °£È£¿Í Ä¡·á.
  • baby care
    À¯¾Æ ¾çÈ£
  • bronchopulmonary care
    ?
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
arsenazo III <chemical> Metallochrome indicator that changes colour when complexed to the calcium ion under physiological conditions. It is used to measure local calcium ion concentrations in vivo.
Pharmacological action: dyes, indicators and reagents.
Chemical name: 2,7-Naphthalenedisulfonic acid, 3,6-bis((2-arsonophenyl)azo)-4,5-dihydroxy-
(12 Dec 1998)
arteriae intercostales posteriores III-XI posterior intercostal arteries 3-11
ATT site <molecular biology> A site on the chromosome of the bacteria E. Coli where the lambda bacteriophage can insert its genome (all of its DNA) so that it can lie dormant and have its DNA reproduced whenever the bacterium reproduces for as long as the bacterium remains healthy (that is, so that it becomes lysogenic).
(09 Oct 1997)
band III protein <protein> A 90 kD protein embedded in the surface of the human erythrocyte membrane, identified as the major anion transport/exchange protein. When the red blood cell is in the lungs, brings chlorine ion into the cell in exchange for bicarbonate.
Analogous proteins exist in other erythrocytes. A dimeric transmembrane glycoprotein, with binding sites for many cytolasmic proteins, including ankyrin, on its cytoplasmic domain.
(18 Nov 1997)
palpebra III The semilunar fold formed by the palpebral conjunctiva at the medial angle of the eye, a fold of the conjunctival mucous membrane found in many animals; normally partially hidden in the medial canthus of the eye when at rest, it may be extended to cover part or all of the cornea in a winking-like action to clean the cornea, as in birds.
Synonym: membrana nictitans, nictitating membrane, palpebra III, palpebra tertia, third eyelid.
Synonym: plica lunata, plica semilunaris of eye, semilunar conjunctival fold.
(05 Mar 2000)
ramus collateralis arteriarum intercostalium posteriorum III-XI Branch arising near angle of rib and descending to run along superior border of rib below; distribution: lower half of intercostal spaces 3-11; anastomoses: collateral branches of anterior intercostal arteries.
Synonym: ramus collateralis arteriarum intercostalium posteriorum III-XI.
(05 Mar 2000)
ramus cutaneus medialis rami dorsalis arteriarum intercostalium posteriorum III-XI Medial cutaneous branch of dorsal branch of posterior intercostal arteries.
See: medial cutaneous branch.
(05 Mar 2000)
ramus dorsalis arteriarum intercostalium posteriorum III-XI Terminal branch (with ventral branch) of the 3rd through 11th posterior intercostal arteries, distributed to thoracic portion of posterior vertebral column, spinal cord and environs, and back.
Synonym: ramus dorsalis arteriarum intercostalium posteriorum III-XI.
(05 Mar 2000)
malocclusion, angle class III Malocclusion in which the mandible is anterior to the maxilla as reflected by the first relationship of the first permanent molar (mesioclusion).
(12 Dec 1998)
gaylus-site <chemical> A yellowish white, translucent mineral, consisting of the carbonates of lime and soda, with water.
Origin: Named after Gay-Lussac, the French chemist.
(20 Mar 1998)
receptor site Point of attachment of viruses, hormones, or other activators to cell membranes.
(05 Mar 2000)
catalytic site <chemistry> The site on an enzyme where the substrate or substrates (the reactants of a chemical or biochemical reaction) attach in order to convert to the product or products of the reaction, at a much higher speed than the substrate would need to convert to the product alone.
(16 Mar 1998)
virus III of rabbits An obsolete name for a latent herpesvirus infection of rabbits.
Origin: the third strain isolated, used for study
(05 Mar 2000)
replication site The in vivo site on DNA of DNA replication.
(05 Mar 2000)
glycogen storage disease type III <disease> An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase (one part of the glycogen debranching enzyme system).
The clinical course of the disease is similar to that of glycogen storage disease type I, but milder. Massive hepatomegaly, which is present in young children, diminishes and occasionally disappears with age. Levels of glycogen with short outer branches are elevated in muscle, liver, and erythrocytes. Six subgroups have been identified, with subgroups type IIIa and type IIIb being the most prevalent.
Inheritance: autosomal recessive
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • child-care
    À°¾ÆÀÇ;º¸À°ÀÇ;À°¾Æ;¾Æµ¿º¸È£(°¡Á¤ÀÇ º¸È£ ¹Û¿¡ ³õ¿©Áø ¾Æµ¿¿¡ ´ëÇÑ Áö¹æ ÀÚÄ¡ ´ÜüÀÇ ÀϽÃÀû º¸È£)
  • community care
    Áö¿ªÀû º¸È£(³ë·ÉÀÚ¿¡ ´ëÇÑ º¹Áö Á¦µµÀÇ Çϳª)
  • day care
    (ÃëÇÐ ÀüÀÇ ¾ÆÀ̸¦ ¸Ã´Â)ÁÖ°£ Ź¾Æ¼ÒÀÇ;º¸À°ÀÇ;(ÃëÇÐ ÀüÀÇ ¾ÆÀ̸¦)Ź¾Æ¼Ò(º¸À°¿ø)¿¡ ¸Ã±â´Ù
  • day care
    µ¥ÀÌÄɾî(¹ÌÃëÇÐ ¾Æµ¿,°í·ÉÀÚ ½ÅüÀå¾ÖÀÚ µîÀ» ÁÖ°£¸¸ µ¹ºÁÁÖ´Â ÀÏ)
  • foster care
    ¼ö¾ç ÀÚ½ÄÀÇ ¾çÀ°
  • home care
    ÀÚÅà ¿ä¾ç(Ä¡·á)
  • intensive care
    (ÁßÁõ ȯÀÚ¿¡ ´ëÇÑ)ÁýÁß(°­È­)Ä¡·á
  • intensive care unit
    ÁýÁß(°­È­)Ä¡·áºÎ(º´µ¿)
  • pastoral care
    Ãæ°í;Á¶¾ð
  • primary care
    ÀÏÂ÷ ÀÇ·á(ÀÀ±Þ Ä¡·á µî ÁÖ°ÅÁö¿¡¼­ ÇàÇÏ´Â Ãʱâ ÀÇ·á)
  • respite care
    ÀϽÃÀû À§Å¹;Àӽà °£È£(°¡Á· ´ë½Å ³ëÀΠȯÀÚ¸¦ ÀϽÃÀûÀ¸·Î º¸»ìÇÇ´Â Á¦µµ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á